Maximus, Inc. $MMS Shares Bought by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP grew its position in Maximus, Inc. (NYSE:MMS) by 2.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,869,573 shares of the health services provider’s stock after buying an additional 36,989 shares during the quarter. Dimensional Fund Advisors LP owned 3.32% of Maximus worth $170,812,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Royal Bank of Canada grew its stake in Maximus by 146.2% in the 1st quarter. Royal Bank of Canada now owns 19,732 shares of the health services provider’s stock valued at $1,345,000 after acquiring an additional 11,716 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Maximus by 0.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock worth $2,351,000 after acquiring an additional 221 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in Maximus by 7.0% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 180,690 shares of the health services provider’s stock worth $12,321,000 after acquiring an additional 11,754 shares during the last quarter. Jane Street Group LLC lifted its holdings in shares of Maximus by 941.2% in the first quarter. Jane Street Group LLC now owns 98,273 shares of the health services provider’s stock valued at $6,701,000 after purchasing an additional 88,835 shares in the last quarter. Finally, Sivia Capital Partners LLC acquired a new stake in shares of Maximus in the second quarter valued at approximately $204,000. 97.21% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of brokerages have recently weighed in on MMS. Weiss Ratings cut shares of Maximus from a “buy (b)” rating to a “hold (c+)” rating in a research note on Tuesday, February 24th. Zacks Research upgraded shares of Maximus from a “hold” rating to a “strong-buy” rating in a report on Tuesday, December 30th. Finally, Wall Street Zen downgraded shares of Maximus from a “buy” rating to a “hold” rating in a report on Monday, February 23rd. One research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Buy”.

Maximus Stock Performance

NYSE MMS opened at $77.26 on Tuesday. The company has a debt-to-equity ratio of 0.88, a current ratio of 2.34 and a quick ratio of 2.34. Maximus, Inc. has a 1-year low of $64.68 and a 1-year high of $100.00. The firm has a market capitalization of $4.21 billion, a P/E ratio of 11.76 and a beta of 0.59. The business’s 50-day simple moving average is $85.58 and its 200-day simple moving average is $86.06.

Maximus (NYSE:MMS) last posted its earnings results on Thursday, February 5th. The health services provider reported $1.85 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.84 by $0.01. The firm had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.37 billion. Maximus had a net margin of 6.92% and a return on equity of 25.30%. The company’s revenue was down 4.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.61 EPS. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. Equities analysts predict that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 2nd. Investors of record on Friday, February 13th were issued a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a dividend yield of 1.7%. The ex-dividend date was Friday, February 13th. This is a positive change from Maximus’s previous quarterly dividend of $0.30. Maximus’s dividend payout ratio (DPR) is presently 20.09%.

Insiders Place Their Bets

In other Maximus news, CFO David Mutryn purchased 1,000 shares of the firm’s stock in a transaction that occurred on Monday, February 9th. The stock was purchased at an average cost of $75.62 per share, with a total value of $75,620.00. Following the transaction, the chief financial officer owned 40,037 shares in the company, valued at approximately $3,027,597.94. This trade represents a 2.56% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Bruce Caswell purchased 3,175 shares of the stock in a transaction that occurred on Tuesday, February 10th. The stock was bought at an average price of $78.45 per share, with a total value of $249,078.75. Following the completion of the acquisition, the chief executive officer owned 328,013 shares in the company, valued at $25,732,619.85. This represents a 0.98% increase in their position. The SEC filing for this purchase provides additional information. 1.80% of the stock is currently owned by corporate insiders.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.